Cargando…

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume

BACKGROUND: O-(2-18 F-fluoroethyl)-L-tyrosine-(FET)-PET may be helpful to improve the definition of radiation target volumes in glioblastomas compared with MRI. We analyzed the relapse patterns in FET-PET after a FET- and MRI-based integrated-boost intensity-modulated radiotherapy (IMRT) of glioblas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piroth, Marc D., Galldiks, Norbert, Pinkawa, Michael, Holy, Richard, Stoffels, Gabriele, Ermert, Johannes, Mottaghy, Felix M., Shah, N. Jon, Langen, Karl-Josef, Eble, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920983/ https://www.ncbi.nlm.nih.gov/pubmed/27342976 http://dx.doi.org/10.1186/s13014-016-0665-z

Ejemplares similares

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison
por: Piroth, Marc D, et al.
Publicado: (2009)

Boosting the acceptance of (18)F-FET PET for image-guided treatment planning with a multi-centric prospective trial
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Combined (18)F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
por: D’Amore, Francesco, et al.
Publicado: (2021)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours
por: Lohmann, Philipp, et al.
Publicado: (2014)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
por: Müller, Marguerite, et al.
Publicado: (2022)

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
por: Pinkawa, Michael, et al.
Publicado: (2012)

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
por: Bauer, Elena Katharina, et al.
Publicado: (2021)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
por: Lohmann, Philipp, et al.
Publicado: (2018)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Evaluation of factors influencing (18)F-FET uptake in the brain
por: Verger, Antoine, et al.
Publicado: (2017)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Congruency of tumour volume delineated by FET PET and MRSI
por: Mauler, Jörg, et al.
Publicado: (2015)

Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study
por: Gagel, Bernd, et al.
Publicado: (2007)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Sequential implementation of DSC-MR perfusion and dynamic [(18)F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
por: Steidl, Eike, et al.
Publicado: (2020)

Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
por: Kocher, Martin, et al.
Publicado: (2021)

(18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection
por: Ort, Jonas, et al.
Publicado: (2021)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
por: Pinkawa, Michael, et al.
Publicado: (2009)

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
por: Galldiks, Norbert, et al.
Publicado: (2016)

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study
por: Pinkawa, Michael, et al.
Publicado: (2010)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
por: Pinkawa, Michael, et al.
Publicado: (2012)

O-(2-[(18)F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres
por: Filss, Christian P., et al.
Publicado: (2017)

Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
por: Werner, Jan-Michael, et al.
Publicado: (2020)

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
por: Poulsen, Sidsel Højklint, et al.
Publicado: (2016)

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis
por: Piroth, Marc D, et al.
Publicado: (2008)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2011)

Current status of PET imaging in neuro-oncology
por: Galldiks, Norbert, et al.
Publicado: (2019)

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016)

Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017)

Automatic derivation of an MR-PET image-based input function for quantification of 18F-FET
por: da Silva, Nuno Andre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_168notih51bt6bm5rpf34msq87